Fingerprint
Dive into the research topics of 'Systemic adverse events following rituximab therapy in patients with Graves' disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Systemic adverse events following rituximab therapy in patients with Graves' disease
D El Fassi, Claus Henrik Nielsen, Michael Peter Junker, H C Hasselbalch, L Hegedüs